Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Ondine Biomedical Inc | VF5 | Nov 15, 2024 | 0.07 | +1.40 |
ONE Gas, Inc. | OG9 | Nov 15, 2024 | 70.50 | 0.00 |
One Liberty Properties, Inc. | O1A | Nov 15, 2024 | 26.80 | +0.75 |
One Media iP Group Plc | 1M9 | Nov 15, 2024 | 0.03 | 0.00 |
One More Level S.A. | 1OJ | Nov 15, 2024 | 0.30 | -3.70 |
One Stop Systems, Inc. | 5MU | Nov 15, 2024 | 2.22 | +2.78 |
OneApex Limited | CWF | Nov 15, 2024 | 0.05 | +0.99 |
ONEFLOW AB | L58 | Nov 15, 2024 | 2.96 | +0.34 |
OneMain Holdings, Inc. | 0S1 | Nov 15, 2024 | 51.98 | +0.89 |
ONEOK, Inc. | ONK | Nov 15, 2024 | 101.26 | -0.86 |
OneSpan Inc. | VDY | Nov 15, 2024 | 16.20 | -1.22 |
OneSpaWorld Holdings Limited - | ORW | Nov 15, 2024 | 17.60 | -1.12 |
Onex Corp. | ONE | Nov 15, 2024 | 77.50 | +0.65 |
Ono Pharmaceutical Co. Ltd | ON4 | Nov 15, 2024 | 10.80 | -0.92 |
ONTEX GROUP NV EO -,01 | OT7 | Nov 15, 2024 | 7.35 | +0.96 |
Onto Innovation Inc. | NNM | Nov 15, 2024 | 150.00 | -4.46 |
Ontrak, Inc. - 9.50% Series A Cumulative Perpetual Preferred | HY1 | Nov 15, 2024 | 0.22 | +3.77 |
Onward Medical NV | 63E | Nov 15, 2024 | 4.58 | -1.29 |
Onxeo | C4X | Nov 15, 2024 | 0.08 | -1.26 |
oOh media Limited | 0OH | Nov 15, 2024 | 0.72 | +0.70 |
OOIL | ORI1 | Nov 15, 2024 | 13.32 | +5.55 |
OP Bancorp | OP3 | Nov 15, 2024 | 15.30 | -1.92 |
OPAP (CR) | GF8 | Nov 15, 2024 | 15.00 | 0.00 |
Opawica Explorations Inc. | OE5 | Nov 15, 2024 | 0.17 | +30.30 |
Open House Co Ltd | O4H | Nov 15, 2024 | 33.00 | -5.71 |
Open Orphan plc | CRO | Nov 15, 2024 | 0.31 | -4.38 |
Open Text Corporation - Common Shares | OTX | Nov 15, 2024 | 27.30 | -3.87 |
Opendoor Technologies Inc | 25M | Nov 15, 2024 | 1.60 | -8.30 |
Opera Limited - American Depositary Shares | 2V8 | Nov 15, 2024 | 17.10 | +1.18 |
Opg Power Venture PLC | OPB | Nov 15, 2024 | 0.09 | -9.31 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.